Skip to main content
. 2019 Feb 4;9:1265. doi: 10.1038/s41598-018-37666-5

Table 1.

In vitro assessment of CMLD011580 pharmacokinetic properties.

CMLD011580
Plasma stability T1/2 (min) 63.4
Mean Plasma Fraction bound (%) 96.8
Microsomal clearance T1/2 (min) 5.09

All pharmacokinetic studies were performed by Cyprotex (United States) following standard protocols.